Skip to main content

Table 3 Summary of adverse drug reactions (ADRs) seen in ≥ 3% of patients (N = 148)

From: Impact of gender, depression severity and type of depressive episode on efficacy and safety of escitalopram: an observational study on major depressive disorder patients in southern India

ADR n (%)
Nausea 29 (19.6)
Headache 26 (17.6)
Diarrhoea 22 (14.9)
Dry mouth 20 (13.5)
Decreased appetite 18 (12.2)
Insomnia 16 (10.8)
Fatigue 14 (9.5)
Constipation 14 (9.5)
Dizziness 12 (8.1)
Tremors 9 (6.1)
Vomiting 9 (6.1)
Sweating 8 (5.4)
Drowsiness 8 (5.4)
Abdominal pain 6 (4.1)
Anxiety 5 (3.4)
Sexual dysfunctiona 3 (4.9)
  1. N, total study population; n, number of patients reporting ADR
  2. aPercentage is calculated out of male patients only (n = 61)